Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to ...
A new prognostic model could potentially predict and stratify the risk for hepatocellular carcinoma (HCC) among patients with chronic hepatitis B (CHB) who are noncirrhotic and not indicated for ...
Previous studies have found that the effectiveness of vaccines can be increased with the knockdown of HBsAg using a small interfering RNA (siRNA). The efficacy of a bivalent mRNA vaccine in ...
There were 43 892 people with HBV monoinfection, and 83 817 with HCV monoinfection in the final study cohort, of which 13 645 (31%) and 35 615 (43%), respectively, had a linked hospital record (Table ...
Without timely and appropriate treatment, hepatitis B virus (HBV) infection can progress to liver fibrosis, cirrhosis or hepatocellular carcinoma (HCC), contributing significantly to global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results